TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma

BACKGROUND: T-cell lymphoma (TCL) is highly aggressive and has a poor prognosis; thus, it is worth exploring biomarkers that may predict clinical outcomes and investigate their potential role in developing targeted therapies. In this study, we characterized the mutation pattern of tumor necrosis fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cunte, Chen, Zheng, Huang, Ling, Zhou, Lingling, Zhu, Lihua, Liu, Sichu, Luo, Gengxin, Li, Wenyu, Zeng, Chengwu, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444556/
https://www.ncbi.nlm.nih.gov/pubmed/34526012
http://dx.doi.org/10.1186/s12935-021-02191-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444556/
https://www.ncbi.nlm.nih.gov/pubmed/34526012
http://dx.doi.org/10.1186/s12935-021-02191-5

Ejemplares similares